- Intricate interpretation of etiology-specific outcomecomparison in patients with hepatocellular carcinoma
-
Kim HY, Dufour JF
- KMID: 2500391
- Clin Mol Hepatol.
- 2020 Apr;26(2):238-239.
- doi: 10.3350/cmh.2020.0051
-
- CITED
-
- Close
- SHARE
-
- Close
- Toll-like receptor 9, a possible blocker of non-alcoholicsteatohepatitis?
-
Jeong SW
- KMID: 2500382
- Clin Mol Hepatol.
- 2020 Apr;26(2):185-186.
- doi: 10.3350/cmh.2020.0046
-
- CITED
-
- Close
- SHARE
-
- Close
- A challenge in distinguishing between acute hepatitis Band acute exacerbation of chronic hepatitis B
-
Baek YH
- KMID: 2500389
- Clin Mol Hepatol.
- 2020 Apr;26(2):233-235.
- doi: 10.3350/cmh.2020.0039
-
- CITED
-
- Close
- SHARE
-
- Close
- KASL clinical practice guidelines for liver cirrhosis:Varices, hepatic encephalopathy, and relatedcomplications
-
The Korean Association for the Study of the Liver (KASL)
- KMID: 2500375
- Clin Mol Hepatol.
- 2020 Apr;26(2):83-127.
- doi: 10.3350/cmh.2019.0010n
-
- CITED
-
- Close
- SHARE
-
- Close
- Limited expression of toll-like receptor 9 on T cells andits functional consequences in patients with nonalcoholicfatty liver disease
-
Yu JH
- KMID: 2500392
- Clin Mol Hepatol.
- 2020 Apr;26(2):240-241.
- doi: 10.3350/cmh.2020.0048
-
- CITED
-
- Close
- SHARE
-
- Close
- Should physicians go out of the way to differentiatebetween acute hepatitis B and acute exacerbation ofchronic hepatitis B?
-
Lee HW
- KMID: 2500380
- Clin Mol Hepatol.
- 2020 Apr;26(2):180-182.
- doi: 10.3350/cmh.2020.0045
-
- CITED
-
- Close
- SHARE
-
- Close
- Does limited expression of toll-like receptor 9 actuallycontribute to T cell activation and liver damage in nonalcoholicsteatohepatitis?
-
Eun HS
- KMID: 2500390
- Clin Mol Hepatol.
- 2020 Apr;26(2):236-237.
- doi: 10.3350/cmh.2020.0040
-
- CITED
-
- Close
- SHARE
-
- Close
- Should you advocate for hepatocellular carcinomasurveillance in patients with alcohol-related liverdisease or non-alcoholic fatty liver disease?
-
Shim JH
- KMID: 2500381
- Clin Mol Hepatol.
- 2020 Apr;26(2):183-184.
- doi: 10.3350/cmh.2020.0042
-
- CITED
-
- Close
- SHARE
-
- Close
- Multimodal sequential treatment for occluded TIPS:Case report and review of literature
-
Matthaeis , Stasi CD, Pizzolante F, Manfredi R, Rapaccini , Miele L
- KMID: 2500387
- Clin Mol Hepatol.
- 2020 Apr;26(2):227-230.
- doi: 10.3350/cmh.2019.0056
-
- CITED
-
- Close
- SHARE
-
- Close
- Fibrolamellar hepatocellular carcinoma-related hyperammonemicencephalopathy: Up to now and next steps
-
Surjan RCT, Santos ESd, Silveira S, Makdissi F, Machado MA
- KMID: 2500388
- Clin Mol Hepatol.
- 2020 Apr;26(2):231-232.
- doi: 10.3350/cmh.2019.0084
-
- CITED
-
- Close
- SHARE
-
- Close
- Switching to systemic therapy after locoregionaltreatment failure: Definition and best timing
-
Ogasawara , Ooka Y, Koroki K, Maruta S, Kanzaki H, Kanayama K, Kobayashi , Kiyono S, Nakamura M, Kanogawa N, Saito T, Kondo T, Suzuki E, Nakamoto S, Tawada A, Chiba T, Arai M, Kato J, Kato N
- KMID: 2500378
- Clin Mol Hepatol.
- 2020 Apr;26(2):155-162.
- doi: 10.3350/cmh.2019.0021n
In patients with unresectable hepatocellular carcinoma (HCC) without both macrovascular invasion and extrahepatic metastasis, the initial treatment choice recommended is transarterial chemoembolization (TACE). Before sorafenib came into wide use, TACE... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparisons between non-alcoholic steatohepatitisand alcohol-related hepatocellular carcinoma
-
Kumar R, Goh BBG, Kam JW, Chang PE, Tan CK
- KMID: 2500384
- Clin Mol Hepatol.
- 2020 Apr;26(2):196-208.
- doi: 10.3350/cmh.2019.0012
Background/Aims: Non-alcoholic liver disease and alcoholic liver disease begin as simple steatosis that may progress to steatohepatitis and ensuing liver-related complications such as cirrhosis and hepatocellular carcinoma (HCC). We explored... -
- CITED
-
- Close
- SHARE
-
- Close
- The dilemma of differentiating between acute hepatitisB and chronic hepatitis B with acute exacerbation: Isquantitative serology the answer?
-
Lall S, Agarwala P, Kumar G, Sharma MK, Gupta E
- KMID: 2500383
- Clin Mol Hepatol.
- 2020 Apr;26(2):187-195.
- doi: 10.3350/cmh.2019.0060
Background/Aims: Acute exacerbations of chronic hepatitis B (CHB-AEs) are common in endemic areas and are often presumed to be acute hepatitis B (AHB) due to their similarities in clinical and... -
- CITED
-
- Close
- SHARE
-
- Close
- Application of transient elastography in nonalcoholicfatty liver disease
-
Zhang X, Wong GLH, Wong VWS
- KMID: 2500376
- Clin Mol Hepatol.
- 2020 Apr;26(2):128-141.
- doi: 10.3350/cmh.2019.0001n
Nonalcoholic fatty liver disease (NAFLD) is currently the most common chronic liver disease worldwide. Although it has become one of the leading causes of cirrhosis and hepatocellular carcinoma in the... -
- CITED
-
- Close
- SHARE
-
- Close
- Drug induced liver injury: East versus West– a systematic review and meta-analysis
-
Low EXS, Zheng Q, Chan E, Lim SG
- KMID: 2500377
- Clin Mol Hepatol.
- 2020 Apr;26(2):142-154.
- doi: 10.3350/cmh.2019.1003
Drug induced liver injury (DILI) may be different in the East compared to the West due to differing disease prevalence, prescribing patterns and pharmacogenetic profiles. To review existing literature on... -
- CITED
-
- Close
- SHARE
-
- Close
- Regulated differentiation of stem cells into an artificial3D liver as a transplantable source
-
Chen F, Wang H, Xiao J
- KMID: 2500379
- Clin Mol Hepatol.
- 2020 Apr;26(2):163-179.
- doi: 10.3350/cmh.2019.0022n
End-stage liver disease is one of the leading causes of death around the world. Since insufficient sources of transplantable liver and possible immune rejection severely hinder the wide application of... -
- CITED
-
- Close
- SHARE
-
- Close
- Limited expression of TLR9 on T cells and its functionalconsequences in patients with nonalcoholic fatty liverdisease
-
Alegre NS, Garcia CC, Billordo L, Ameigeiras B, Poncino D, Benavides , Colombato , Cherñavsky AC
- KMID: 2500386
- Clin Mol Hepatol.
- 2020 Apr;26(2):216-226.
- doi: 10.3350/cmh.2019.0074
Background/Aims: Toll-like receptors (TLRs) modulate T cell responses in diverse diseases. Co-stimulation of T cell activation via TLR9 induces production of interferon gamma (IFN-γ), priming of which is critical for... -
- CITED
-
- Close
- SHARE
-
- Close
- Trends in the prevalence of chronic liver disease in theKorean adult population, 1998–2017
-
Park SH, Plank LD, Suk KT, Park YE, Lee J, Choi JH, Heo NY, Park J, Kim TO, Moon YS, Kim HK, Jang HJ, Park HY, Kim DJ
- KMID: 2500385
- Clin Mol Hepatol.
- 2020 Apr;26(2):209-215.
- doi: 10.3350/cmh.2019.0065
Background/Aims: Data on the trends in the prevalence of chronic liver disease (CLD) in Korea are scarce. This study aimed to evaluate whether the CLD prevalence changed between 1998–2001 and... -
- CITED
-
- Close
- SHARE
-
- Close
